ARMISTICE CAPITAL LLC 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-06-22 08:14 am Sale |
2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS |
ARMISTICE CAPITAL LLC | 0 0.000% |
-1,490 (Position Closed) |
Filing |
| 2020-09-16 4:56 pm Purchase |
2020-09-14 | 13D | ReShape Lifesciences Inc. RSLS |
ARMISTICE CAPITAL LLC | 1,490 97.900% |
138 (+10.20%) |
Filing |
| 2020-08-20 4:50 pm Purchase |
2020-08-13 | 13D | ReShape Lifesciences Inc. RSLS |
ARMISTICE CAPITAL LLC | 1,352 97.700% |
2 (+0.12%) |
Filing |